Press Releases

Clovis Oncology announced today the pricing of an underwritten public offering of 3333334 shares of its common stock at $72.00 per share before underwriting discounts and commissions. The size of the offering was upsized from...

Cancer vaccine specialist Targovax today announced that it has raised a total of $3.6 million to accelerate development of its RAS mutation-targeted therapeutic cancer vaccine pipeline specifically lead candidate TG01 for pancreatic cancer. The funds...

Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, announces today that it has successfully completed a phase III clinical trial in adult and paediatric patients with impetigo involving Ozenoxacin formulated as a topical...

Biogen Idec Inc. announced today that its 2013 Annual Shareholder Meeting will be webcast live on Wednesday June 12 2013 at 9:00 a.m. ET. To access the live webcast please visit Biogen Idec’s Investors section at www.biogenidec.com. An archived...

Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the appointment of Udo Steinhauer as fine chemicals market director within the synthesis business unit...

The UAE is currently witnessing progress in the global medical tourism industry today. Being a melting pot of cultures and located only a few hours away from one third of the world’s population, the country is increasingly becoming...

The BBRSC Programme combines Chemistry and Biochemical Engineering at UCL with Almac’s Biocatalysis Group. The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically...